Legal & General Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Buy |
52,307
+1,959
| +4% | +$25.7K | ﹤0.01% | 2349 |
|
|
2025
Q1 | $1.11M | Buy |
50,348
+56
| +0.1% | +$1.23K | ﹤0.01% | 2151 |
|
|
2024
Q4 | $1.34M | Buy |
50,292
+6,635
| +15% | +$177K | ﹤0.01% | 2143 |
|
|
2024
Q3 | $1.17M | Buy |
43,657
+4,405
| +11% | +$118K | ﹤0.01% | 2181 |
|
|
2024
Q2 | $707K | Buy |
39,252
+10,761
| +38% | +$194K | ﹤0.01% | 2305 |
|
|
2024
Q1 | $520K | Buy |
28,491
+11,834
| +71% | +$216K | ﹤0.01% | 2410 |
|
|
2023
Q4 | $182K | Buy |
16,657
+13,127
| +372% | +$144K | ﹤0.01% | 2713 |
|
|
2023
Q3 | $20.2K | Sell |
3,530
-540
| -13% | -$3.09K | ﹤0.01% | 3022 |
|
|
2023
Q2 | $31.5K | Buy |
4,070
+436
| +12% | +$3.38K | ﹤0.01% | 2955 |
|
|
2023
Q1 | $24.2K | Hold |
3,634
| – | – | ﹤0.01% | 3016 |
|
|
2022
Q4 | $32.5K | Buy |
3,634
+1,060
| +41% | +$9.47K | ﹤0.01% | 3031 |
|
|
2022
Q3 | $25K | Buy |
2,574
+58
| +2% | +$563 | ﹤0.01% | 3147 |
|
|
2022
Q2 | $20K | Sell |
2,516
-2,122
| -46% | -$16.9K | ﹤0.01% | 3235 |
|
|
2022
Q1 | $44K | Sell |
4,638
-13
| -0.3% | -$123 | ﹤0.01% | 3021 |
|
|
2021
Q4 | $71K | Buy |
4,651
+2,786
| +149% | +$42.5K | ﹤0.01% | 2971 |
|
|
2021
Q3 | $31K | Hold |
1,865
| – | – | ﹤0.01% | 3113 |
|
|
2021
Q2 | $40K | Buy |
+1,865
| New | +$40K | ﹤0.01% | 3021 |
|